https://doi.org/10.4081/gc.2025.13768
The role of geriatric multidimensional assessment in elderly patients with severe aortic stenosis and candidates for transcatheter aortic valve implantation
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 1 July 2025
Severe aortic stenosis (AS) is a prevalent valvular condition among older adults, primarily resulting from the calcification and fibrosis of the aortic valve. Surgical aortic valve replacement and transcatheter aortic valve implantation (TAVI) are the main therapeutic options. TAVI has emerged as the preferred approach for elderly and frail patients deemed unsuitable for conventional surgery. This study highlights the critical role of Comprehensive Geriatric Assessment, including frailty evaluation, in identifying elderly patients best suited for TAVI. Tools such as the Essential Frailty Toolset, Clinical Frailty Scale, and the Multidimensional Prognostic Index have demonstrated efficacy in predicting postoperative mortality and disability. Multidimensional assessments, encompassing functional tests such as the 6-Minute Walking Test, enable enhanced risk stratification and personalized care planning. The findings emphasize the importance of a multidisciplinary approach in optimizing outcomes for geriatric patients with severe AS, focusing on improving clinical results and quality of life.
Downloads
Rostagno C. Heart valve disease in elderly. World J Cardiol 2019;11:71-83. DOI: https://doi.org/10.4330/wjc.v11.i2.71
Reardon MJ, Van Mieghem NM, Popma JJ, et al. Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. N Engl J Med 2017;376:1321-31. DOI: https://doi.org/10.1056/NEJMoa1700456
Bobet AS, Brouessard C, Le Tourneau T, et al. Length of stay in older patients undergoing transcatheter aortic valve replacement: value of a geriatric approach. Gerontology 2022;68:746-54. DOI: https://doi.org/10.1159/000518821
Baumgartner H, Hung J, Bermejo J, et al. Recommendations on the echocardiographic assessment of aortic valve stenosis: a focused update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. J Am Soc Echocardiogr 2017;30:372-92. DOI: https://doi.org/10.1016/j.echo.2017.02.009
Monin JL, Monchi M, Gest V, et al. Aortic stenosis with severe left ventricular dysfunction and low transvalvular pressure gradients: risk stratification by low-dose dobutamine echocardiography. J Am Coll Cardiol 2001;37:2101-7. DOI: https://doi.org/10.1016/S0735-1097(01)01339-0
Goudzwaard JA, Chotkan S, De Ronde-Tillmans MJAG, et al. Multidimensional prognostic index and outcomes in older patients undergoing transcatheter aortic valve implantation: survival of the fittest. J Clin Med 2021;10:3529. DOI: https://doi.org/10.3390/jcm10163529
Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS guidelines for the management of valvular heart disease: developed by the task force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2022;43:561-632. Erratum in: Eur Heart J 2022;43:2022. DOI: https://doi.org/10.1093/eurheartj/ehac051
Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. Circulation 2017;135:e1159-95. DOI: https://doi.org/10.1161/CIR.0000000000000503
Leon MB, Smith CR, Mack MJ, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med 2016;374:1609-20. DOI: https://doi.org/10.1056/NEJMoa1514616
Badiani S, Bhattacharyya S, Lloyd G. Role of echocardiography before transcatheter aortic valve implantation (TAVI). Curr Cardiol Rep 2016;18:38. DOI: https://doi.org/10.1007/s11886-016-0715-z
Postolache A, Sperlongano S, Lancellotti P. TAVI after more than 20 years. J Clin Med 2023;12:5645. DOI: https://doi.org/10.3390/jcm12175645
Achenbach S, Delgado V, Hausleiter J, et al. SCCT expert consensus document on computed tomography imaging before transcatheter aortic valve implantation (TAVI)/transcatheter aortic valve replacement (TAVR). J Cardiovasc Comput Tomogr 2012;6:366-80. DOI: https://doi.org/10.1016/j.jcct.2012.11.002
Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010;363:1597-607. DOI: https://doi.org/10.1056/NEJMoa1008232
Kodali SK, Williams MR, Smith CR, et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med 2012;366:1686-95. DOI: https://doi.org/10.1056/NEJMoa1200384
Kalogeropoulos AS, Redwood SR, Allen CJ, et al. A 20-year journey in transcatheter aortic valve implantation: evolution to current eminence. Front Cardiovasc Med 2022;9:971762. DOI: https://doi.org/10.3389/fcvm.2022.971762
Popma JJ, Deeb GM, Yakubov SJ, et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med 2019;380:1706-15. DOI: https://doi.org/10.1056/NEJMoa1816885
Vilalta V, Asmarats L, Ferreira-Neto AN, et al. Incidence, clinical characteristics, and impact of acute coronary syndrome following transcatheter aortic valve replacement. JACC Cardiovasc Interv 2018;11:2523-33. DOI: https://doi.org/10.1016/j.jcin.2018.09.001
Goudzwaard JA, de Ronde-Tillmans MJAG, de Jager TAJ, et al. Incidence, determinants and consequences of delirium in older patients after transcatheter aortic valve implantation. Age Ageing 2020;49:389-94. DOI: https://doi.org/10.1093/ageing/afaa001
Phu S, Kirk B, Bani Hassan E, et al. The diagnostic value of the short physical performance battery for sarcopenia. BMC Geriatr 2020;20:242. DOI: https://doi.org/10.1186/s12877-020-01642-4
Edwards FH, Cohen DJ, O’Brien SM, et al. Development and validation of a risk prediction model for in-hospital mortality after transcatheter aortic valve replacement. JAMA Cardiol 2016;1:46-52. DOI: https://doi.org/10.1001/jamacardio.2015.0326
Afilalo J, Lauck S, Kim DH, et al. Frailty in older adults undergoing aortic valve replacement: the FRAILTY-AVR study. J Am Coll Cardiol 2017;70:689-700. DOI: https://doi.org/10.1016/j.jacc.2017.06.024
Prendiville T, Leahy A, Quinlan L, et al. Rockwood clinical frailty scale as a predictor of adverse outcomes among older adults undergoing aortic valve replacement: a protocol for a systematic review. BMJ Open 2022;12:e049216. DOI: https://doi.org/10.1136/bmjopen-2021-049216
Ming-yu AC, Akodad M, Chatfield A, et al. Frailty assessment of transcatheter aortic valve replacement patients: contemporary practice and future directions. Structural Heart 2021;5:357-66. DOI: https://doi.org/10.1080/24748706.2021.1921318
Shimura T, Yamamoto M, Kano S, et al. Impact of the clinical frailty scale on outcomes after transcatheter aortic valve replacement. Circulation 2017;135:2013-24. DOI: https://doi.org/10.1161/CIRCULATIONAHA.116.025630
Seiffert M, Sinning JM, Meyer A, et al. Development of a risk score for outcome after transcatheter aortic valve implantation. Clin Res Cardiol 2014;103:631-40. DOI: https://doi.org/10.1007/s00392-014-0692-4
Drudi LM, Ades M, Asgar A, et al. Interaction between frailty and access site in older adults undergoing transcatheter aortic valve replacement. JACC Cardiovasc Interv 2018;11:2185-92. DOI: https://doi.org/10.1016/j.jcin.2018.06.037
Pilotto A, Veronese N, Daragjati J, et al. Using the multidimensional prognostic index to predict clinical outcomes of hospitalized older persons: a prospective, multicenter, international study. J Gerontol A Biol Sci Med Sci 2019;74:1643-9. DOI: https://doi.org/10.1093/gerona/gly239
Van Mourik MS, van der Velde N, Mannarino G, et al. Value of a comprehensive geriatric assessment for predicting one-year outcomes in patients undergoing transcatheter aortic valve implantation: results from the CGA-TAVI multicentre registry. J Geriatr Cardiol 2019;16:468-77.
Solway S, Brooks D, Lacasse Y, Thomas S. A qualitative systematic overview of the measurement properties of functional walk tests used in the cardiorespiratory domain. Chest 2001;119:256-70. DOI: https://doi.org/10.1378/chest.119.1.256
Casanova C, Celli BR, Barria P, et al. The 6-min walk distance in healthy subjects: reference standards from seven countries. Eur Respir J 2011;37:150-6. DOI: https://doi.org/10.1183/09031936.00194909
Green P, Cohen DJ, Généreux P, et al. Relation between six-minute walk test performance and outcomes after transcatheter aortic valve implantation (from the PARTNER trial). Am J Cardiol 2013;112:700-6. DOI: https://doi.org/10.1016/j.amjcard.2013.04.046
Ternacle J, Hecht S, Eltchaninoff H, et al. Durability of transcatheter aortic valve implantation. EuroIntervention 2024;20:e845-64. DOI: https://doi.org/10.4244/EIJ-D-23-01050
Thyregod HGH, Jørgensen TH, Ihlemann N, et al. Transcatheter or surgical aortic valve implantation: 10-year outcomes of the NOTION trial. Eur Heart J 2024;45:1116-24. DOI: https://doi.org/10.1093/eurheartj/ehae043
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.